|Last Price$69.66||Day Change (%)-0.40%|
|Open Price$70.02||Day Change ($)-0.28|
|Day Range69.49–70.55||52-Week Range44.80–76.68|
As of Fri 5/22/2015 5:00:00 PM | USD
Mylan Confirms First-to-File Patent Challenge Relating to Minivelle®
Mylan Launches Gilead Sciences' Sovaldi® Tablets in India
Mylan Launches Generic Seasonale® Tablets
Mylan adjusted income is one cent short of views
Mylan Launches Generic Sofosbuvir Tablets, MyHep™, in India
Perrigo rejects new bid offer from Mylan
On heels of rejection, Mylan gets letter from Teva
Mylan ups the ante for Perrigo with $33 billion bid
Watson Pharmaceuticals WPI scored big Tuesday when the Food and Drug Administration approved the firm's generic fentanyl patch. We may modestly increase our fair value estimate for Watson and will maintain our fair value estimate for competitor Mylan Laboratories MYL . The pain patch is one of the ...
Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...